Proactive Measures Taken by Children’s Hospitals Amid RSV Drug Shortage to Handle Surge in Admissions
A supply shortage means a drug that can prevent respiratory syncytial virus (RSV) in infants won’t have a major immediate impact, children’s hospitals said, and they are preparing for a surge in admissions this respiratory disease season. “Widespread access [to the new antibody drug] will take time across many sectors of the pediatric population and …